Fludarabine Injection, Solution
Product Images NDC 63323-192

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Fludarabine (NDC 63323-192). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Logo (Fklz Address)

FDA Label Image

Carton (Fludarabine Carton)

Fludarabine Phosphate Injection USP 25 mg/mL solution in a 2 mL single-dose vial by Fresenius Kabi USA, LLC. The label states 50 mg per 2 mL, preservative free, for intravenous use only. It indicates the product is a cytotoxic agent and should be refrigerated.*

FDA Label Image

Fludarabine-structure (Fludarabine Phosphate Injection Usp Figure 1 Fludarabine Injection Structure)

Chemical structure of Fludarabine phosphate, showing its molecular components including phosphate group, sugar moiety, and purine base.*

FDA Label Image

Vial (Fludarabine Vial)

Fludarabine Phosphate 50 mg per 2 mL (25 mg/mL) injection solution for intravenous use in a 2 mL single-dose vial. Label indicates the product is preservative free and a cytotoxic agent. Manufactured by Fresenius Kabi USA, LLC with NDC 63323-192.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.